- Report
- August 2025
- 195 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- June 2025
- 110 Pages
Global
From €5254EUR$5,950USD£4,559GBP
- Report
- August 2025
- 195 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- August 2025
- 181 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- August 2025
- 196 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- August 2025
- 180 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- April 2025
- 175 Pages
Global
From €3965EUR$4,490USD£3,440GBP
- Report
- April 2025
- 175 Pages
Global
From €3965EUR$4,490USD£3,440GBP
- Report
- April 2025
- 175 Pages
Global
From €3965EUR$4,490USD£3,440GBP
- Report
- April 2025
- 175 Pages
Global
From €3965EUR$4,490USD£3,440GBP
- Report
- April 2025
- 175 Pages
Global
From €3965EUR$4,490USD£3,440GBP
- Report
- April 2025
- 175 Pages
Global
From €3965EUR$4,490USD£3,440GBP
- Report
- April 2025
- 175 Pages
Global
From €3965EUR$4,490USD£3,440GBP
- Report
- April 2025
- 175 Pages
Global
From €3965EUR$4,490USD£3,440GBP
- Report
- April 2025
- 175 Pages
Global
From €3965EUR$4,490USD£3,440GBP
- Report
- April 2025
- 200 Pages
Global
From €3965EUR$4,490USD£3,440GBP
- Report
- August 2025
- 181 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- August 2025
- 197 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- April 2025
- 200 Pages
Global
From €7020EUR$7,950USD£6,091GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1324EUR$1,500USD£1,149GBP

The Fibrin market is a segment of the Hematological Drugs market, which includes drugs used to treat blood-related diseases. Fibrin is a protein that helps the body form blood clots, and is used to treat conditions such as deep vein thrombosis, pulmonary embolism, and bleeding disorders. Fibrin is also used in surgical procedures to help control bleeding.
Fibrin is available in a variety of forms, including topical creams, injectable solutions, and topical gels. It is also available in combination with other drugs, such as anticoagulants and thrombolytics.
The Fibrin market is highly competitive, with many companies offering products in different forms and combinations. Some of the major players in the market include Pfizer, Novo Nordisk, Sanofi, Bayer, and CSL Behring. Show Less Read more